Related Experiment Video
Updated: Mar 6, 2026

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity
Nashwa Ismail Hashaad1, Rasha Mohamed Fawzy1, Abeer Ahmed Abo Elazem2
1Department of Rheumatology, Rehabilitation and Physical Medicine, Benha University School of Medicine, Benha, Egypt.
Insights
Elevated serum calreticulin (CRT) levels are significantly higher in children with juvenile idiopathic arthritis (JIA). These elevated CRT levels correlate with disease activity and severity, suggesting CRT as a potential biomarker for JIA.
Area of Science:
- Rheumatology
- Immunology
- Biochemistry
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disease affecting children.
- Accurate biomarkers for JIA disease activity and severity are crucial for effective management.
Purpose of the Study:
- To investigate the relationship between serum calreticulin (CRT) levels and disease activity/severity in JIA patients.
Main Methods:
- Serum CRT levels were measured using ELISA in 60 JIA patients and 50 healthy controls.
- Disease activity was assessed using the juvenile arthritis disease activity score 27 (JADAS-27).
- Disease severity was evaluated using ultrasonography (US) and power Doppler US (PDUS).
Main Results:
- Mean serum CRT levels were significantly higher in JIA patients (8.6±1.2 ng/mL) compared to controls (5.02±0.77 ng/mL) (p=0.001).
- Serum CRT levels showed significant positive correlations with disease duration, joint counts, visual analog scale, ESR, JADAS-27, CRP, RF titer, and ultrasonographic findings (synovitis, neovascularization).
Conclusions:
- Elevated serum CRT levels are associated with JIA.
- CRT may serve as a novel biomarker for assessing disease activity and severity in juvenile idiopathic arthritis.
Objective:
This study aimed to investigate the relations between calreticulin (CRT) serum level and both disease activity and severity parameters in juvenile idiopathic arthritis (JIA).
Material And Methods:
In this study, 60 children with JIA and 50 age-and-sex-matched healthy subjects were enrolled. The assessment of the disease activity was done using juvenile arthritis disease activity score 27 (JADAS-27). The assessment of disease severity was done via gray-scale ultrasonography (US) and power Doppler US (PDUS). Enzyme-linked immunosorbent assay (ELISA) was used to assay the serum level of human CRT.
Results:
The mean serum CRT levels in JIA patients was 8.6±1.2 ng/mL and showed a highly significant increase (p=0.001) as compared to the mean serum levels in the controls (5.02±0.77 ng/mL). There were statistically significant positive correlations between the serum CRT levels and disease duration, tender joint count, swollen joint count, visual analog scale, erythrocyte sedimentation rate, JADAS-27, C-reactive protein, rheumatoid factor titer, and ultrasonographic grading for synovitis and neovascularization.
Conclusion:
Elevated serum CRT levels in JIA patients and its correlations with JIA disease activity and severity parameters signified that CRT might be used as a novel biomarker for disease activity and severity in JIA.
Related Concept Videos
The JAK-STAT Signaling Pathway
Serum Studies: Renal Function Tests

